rf1v vaccine

Vaccineexperimental

Clinical trial activity

5 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2004 (NCT00097396)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • rf1v vaccine
  • rfiv vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05506969Phase 2Aug 9, 2022Department of Defense, Dynavax Technologies Corporation
NCT01122784Phase 2Jul 1, 2010DynPort Vaccine Company LLC
NCT00332956Phase 2May 1, 2006Algorithme Pharma Inc, Benchmark Research, DynPort Vaccine Company LLC, Meridian Clinical Research, LLC, Palm Beach Research Center, Primary Physicians Research, Inc, University of Kentucky
NCT00246467Phase 1Oct 1, 2005Miami Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), PharmAthene
NCT00097396Phase 1Nov 1, 2004DynPort Vaccine Company LLC, University of Kentucky
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
DynPort Vaccine Company LLCFor profit3322004
University of KentuckyAcademic/Hospital2022004
Algorithme Pharma IncFor profit1012006
Benchmark ResearchFor profit1012006
Department of DefenseGovernment1012022
Dynavax Technologies CorporationFor profit1112022
Meridian Clinical Research, LLCFor profit1012006
Miami Clinical ResearchFor profit1012005
National Institute of Allergy and Infectious Diseases (NIAID)Government1012005
Palm Beach Research CenterFor profit1012006
PharmAtheneFor profit1112005
Primary Physicians Research, IncFor profit1012006
12 organizations
Page 1 / 1